51933-78-9

Usage

Uses

Used in Chemical Synthesis:
5-Bromo-2-methylsulfanyl-pyridine is used as an intermediate in the synthesis of various organic compounds. Its unique structure allows for the formation of new chemical bonds and the creation of a wide range of derivatives, making it a valuable building block in the field of organic chemistry.
Used in Pharmaceutical Research:
5-Bromo-2-methylsulfanyl-pyridine is used as a starting material in the development of new pharmaceutical compounds. Its versatile structure can be modified to create potential drug candidates with specific therapeutic properties, contributing to the advancement of medicine.
Used in Biochemical Studies:
5-Bromo-2-methylsulfanyl-pyridine is used as a research tool in biochemical studies. Its interaction with various biomolecules can provide insights into the mechanisms of biological processes and help in the understanding of complex molecular systems.
Used in Analytical Chemistry:
5-Bromo-2-methylsulfanyl-pyridine is used as a reagent or a reference compound in analytical chemistry. Its distinct chemical properties can be utilized for the identification, quantification, or separation of other compounds, aiding in the development of analytical methods and techniques.

InChI:InChI=1/C6H6BrNS/c1-9-6-3-2-5(7)4-8-6/h2-4H,1H3

Upstream product

• 624-28-2 2,5-dibromopyridine 
• 5188-07-8 sodium thiomethoxide 
• 624-92-0 Dimethyldisulphide 
• 626-55-1 3-Bromopyridine 
• 16663-58-4 3-bromopyridinetrifluoroborate 
• 53939-30-3 5-bromo-2-chloropyridine 
• 867-44-7 S-Methylisothiourea sulfate 

Downstream Products

• 149805-95-8 6-(methylthio)nicotinaldehyde 
• 85330-63-8 2,5-bis-methanesulfonyl-pyridine 
• 321438-86-2 6-(methylthio)pyridin-3-ylboronic acid 
• 1359818-17-9 5-(4-isopropoxybenzyl)-2-(methylthio)pyrimidine 
• 1359818-19-1 4-(4-chlorobenzyl)-5-(4-isopropoxybenzyl)-2-(methylthio)pyrimidine 
• 1359818-20-4 4-(4-chlorobenzyl)-5-(4-isopropoxybenzyl)-2-(methanesulfonyl)pyrimidine 
• 1359818-16-8 5-(4-isopropoxy-α-hydroxybenzyl)-2-(methylthio)pyrimidine 
• 849934-89-0 2-(methylthio)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine 
• 1052138-94-9 2-(methylsulfonyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine 
• 1416000-08-2 2-(6-(methylsulfonyl)pyridin-3-yl)-10-(3-(trifluoromethyl)phenyl)pyrido[3,2-c][1,5] naphthyridin-9(10H)-one 
• 1416000-41-3 2-(6-(methylthio)pyridin-3-yl)-10-(3-(trifluoromethyl)phenyl)pyrido[3,2-c][1,5]naphthyridin-9(10H)-one 
• 1193244-90-4 C₆H₆BrNOS 
• 1193244-90-4 (S)-5-bromo-2-(methylsulfinyl)pyridine 
• 1093121-42-6 C₁₆H₁₇NO₆S 

Relevant academic research and scientific papers

PYRAZOLOPYRIMIDINE DERIVATIVE AND USE THEREOF AS PI3K INHIBITOR

The present invention discloses a series of pyrazolopyrimidine derivatives and use thereof in preparing a medicament for treating a disease related to PI3K, and in particular, discloses a derivative compound of formula (I), a tautomer thereof or a pharmaceutically acceptable composition thereof.

PROCESS FOR PREPARING THE COMPOUND 2,2-DIFLUORO-N-((1R,2S)-3-FLUORO-1-HYDROXY-1-(4-(6-(S-METHYLSULFONIMIDOYL)PYRIDIN-3-YL)PHENYL)PROPAN-2-YL)ACETAMIDE

The present invention provides a novel process for preparing a diastereomeric mixture of the phenicol of Formula (1), its use for the treatment of bacterial infections in animals, and veterinary compositions containing the Formula (1) compound, diastereom

NOVEL APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS

The present invention relates to inhibitors of apoptosis signal-regulating kinase 1 ("ASK1"), a process for synthesis of the compounds of the present invention, composition comprising the compounds and use of the compounds for inhibition of ASK1.

Furanone derivatives, preparation method and use thereof

The invention relates to a novel selective cyclooxygenase-2 inhibitor compound, a preparation method and use and belongs to the field of chemical drugs. The compound represented by a formula (I) shown in the description can be used for inhibiting cyclooxy

TRICYCLIC COMPOUND FOR BROMODOMAIN-CONTAINING PROTEIN INHIBITOR AND PREPARATION, PHARMACEUTICAL COMPOSITION, AND APPLICATION THEREOF

The present applicationpresent application relates to a compound represented by Formula (III) or a pharmaceutically acceptable salt, solvent compound, active metabolite, crystal polymorph, ester, isomer, or prodrug thereof. The application further provides a pharmaceutical composition comprising the compound represented by Formula (III) and a use thereof for preparing a bromodomain inhibitor for preventing or treating various diseases, such as inflammation and cancer, related to the bromodomain.

Cesium carbonate-promoted synthesis of aryl methyl sulfides using: S -methylisothiourea sulfate under transition-metal-free conditions

In the presence of cesium carbonate, an efficient synthesis of aryl methyl sulfides by the reactions of aryl halides with commercially available S-methylisothiourea sulfate is developed. This odourless and highly crystalline solid can be used as the subst

GLUCOKINASE ACTIVATORS AND METHODS OF USING SAME

A compound, enantiomer, prodrug, diastereomer, or salt is provided which is an activator of the enzyme glucokinase and thus is believed to be useful in treating diabetes and related diseases, which compound has the structure (I). A method for treating diabetes and related disease employing the compound, enantiomer, prodrug, diastereomer, or salt is also provided.

NOVEL AZA-OXO-INDOLES FOR THE TREATMENT AND PROPHYLAXIS OF RESPIRATORY SYNCYTIAL VIRUS INFECTION

The invention provides novel compounds having the general formula: wherein R1, R2, R3, R4, R5, W and X are as described herein, compositions including the compounds and methods of using the compounds.

Pyridonaphthyridine PI3K/MTOR Dual Inhibitors and Preparation and Use Thereof

The present invention relates to a pyridonaphthyridine compound as represented by general formula (I), which has a dual PI3K and mTOR inhibition effect, and its pharmaceutically acceptable salt, stereoisomer and deuteride thereof, wherein R1, R2, R3, R4, R5, R6, R7 and X are as defined in the specification; the present invention also relates to a method for preparing said compound, a pharmaceutical composition and a pharmaceutical formulation containing said compound, and uses of said compound in treating and/or preventing a proliferative disease and in the manufacture of a medicament for treating and/or preventing a proliferative disease.

PYRIDONAPHTHYRIDINE PI3K/MTOR DUAL INHIBITORS AND PREPARATION AND USE THEREOF

The present invention relates to a pyridonaphthyridine compound as represented by general formula (I), which has a dual PI3K and mTOR inhibition effect, and its pharmaceutically acceptable salt, stereoisomer and deuteride thereof, wherein R1, R2, R3, R4, R5, R6, R7 and X are as defined in the specification; the present invention also relates to a method for preparing said compound, a pharmaceutical composition and a pharmaceutical formulation containing said compound, and uses of said compound in treating and/or preventing a proliferative disease and in the manufacture of a medicament for treating and/or preventing a proliferative disease.